JP Morgan Maintains Neutral on Gentex, Lowers Price Target to $27

Benzinga Newsdesk www.benzinga.com Negative 91.1%

Neg 91.1% Neu 0% Pos 0%

JP Morgan analyst Ryan Brinkman maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $28 to $27.